Crosspoint Capital Strategies’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,514	Closed	-$265K	–	1009
2015 Q3	$265K	Sell	2,514 -509	-17%	-$53.7K	0.31%	80
2015 Q2	$413K	Buy	3,023 +722	+31%	+$98.6K	0.12%	108
2015 Q1	$287K	Buy	2,301 +143	+7%	+$17.8K	0.14%	112
2014 Q4	$195K	Buy	+2,158	New	+$195K	0.07%	193